Welcome to our dedicated page for Diversified Healthcare Tr news (Ticker: DHC), a resource for investors and traders seeking the latest updates and insights on Diversified Healthcare Tr stock.
Diversified Healthcare Trust (Nasdaq: DHC) is a Maryland real estate investment trust focused on owning high-quality healthcare properties across the United States. Its portfolio includes senior living communities, medical office buildings and life science properties, and the trust is managed by The RMR Group, an alternative asset manager specializing in commercial real estate. This news page aggregates company announcements and market updates related to DHC’s operations, portfolio and capital structure.
Readers can find press releases on quarterly and annual financial results, including summaries of performance for the senior housing operating portfolio (SHOP) and the office and life science properties. DHC regularly issues updates on its capital recycling program, such as the sale of non-core properties and the use of proceeds to repay or refinance debt, including senior secured notes. News items also cover changes in the operator base for DHC’s senior living communities, including the transition of management agreements from AlerisLife Inc. to multiple senior living operators.
In addition, this feed includes announcements of regular quarterly cash distributions on DHC’s common shares, along with explanations of the factors the Board of Trustees considers when setting distribution rates. Coverage may also reference DHC’s participation in joint ventures, such as its minority equity interest in a venture that owns Vertex Pharmaceuticals Incorporated’s headquarters in the Boston Seaport district, as disclosed by The RMR Group.
Investors and observers who follow DHC’s news can use this page to monitor developments in its healthcare real estate portfolio, debt financing activities, operator transitions and distribution declarations. For those analyzing DHC stock, the news stream provides context on how the trust manages its properties, capital and relationships with operators and tenants over time.
Diversified Healthcare Trust (Nasdaq: DHC) reported a net loss of $109.4 million or $0.46 per share for Q2 2022, despite a $6.3 million increase in NOI driven by improved senior living occupancy. The company achieved a 23.3% rise in adjusted EBITDAre and saw a 9.1% increase in rental rates on a segment of their Office Portfolio. However, normalized FFO was negative at ($10.4 million) or ($0.04) per share. The balance sheet strengthened with a $108 million equity sale and a $500 million redemption of senior notes, reducing interest expenses by approximately $49 million.
Diversified Healthcare Trust (Nasdaq: DHC) announced the acquisition of a property at 47071 Bayside Parkway, Fremont, CA, for $82 million. This acquisition reflects a GAAP cap rate of 6.5% and adds to DHC’s growing life science portfolio in the San Francisco Bay area. The property, fully leased to Alamar Bioscience through January 2034, spans 89,000 square feet. DHC now owns four life science assets in this market, totaling approximately 327,000 square feet. The company holds assets worth about $6.8 billion across 36 states and D.C.
Diversified Healthcare Trust (Nasdaq: DHC) has announced a quarterly dividend of $0.01 per common share, totaling $0.04 annually. The dividend will be paid to shareholders of record on July 25, 2022, with distribution expected around August 18, 2022. DHC, which operates a diverse portfolio of healthcare properties worth approximately $6.8 billion, aims for broad diversification across healthcare services types.
Diversified Healthcare Trust (Nasdaq: DHC) will release its second quarter 2022 financial results on August 3, 2022, after Nasdaq's market close. A conference call with CEO Jennifer Francis and CFO Richard Siedel is scheduled for August 4, 2022, at 10:00 a.m. ET. Investors can access the call by dialing (877) 329-4297 or (412) 317-5435 for international participants. A replay will be available until August 11, 2022. DHC owns approximately $6.8 billion in healthcare properties across 36 states and Washington, D.C., including over 100 life science and medical office properties totaling nine million square feet.
Diversified Healthcare Trust (Nasdaq: DHC) has announced the sale of a 10% equity interest in its life science complex located in Boston for approximately $108 million. This transaction values the property at $1.7 billion after accounting for $620 million of existing debt. DHC intends to utilize the proceeds for capital expenditures, debt reduction, and general business purposes. The complex is nearly fully leased to Vertex Pharmaceuticals and reflects DHC's significant healthcare property portfolio valued at $6.8 billion.
Diversified Healthcare Trust (Nasdaq: DHC) held its 2022 Annual Meeting of Shareholders, where significant outcomes included the re-election of key trustees. Lisa Harris Jones received 80.0% support, John L. Harrington 72.3%, Jennifer F. Francis 97.7%, and Adam D. Portnoy 67.3%. Shareholders approved executive compensation with a favorable vote of 90.3% and ratified the appointment of Deloitte & Touche LLP as independent auditors with 99.4% support. DHC operates a diverse portfolio valued at approximately $6.8 billion across the healthcare sector.
Diversified Healthcare Trust (Nasdaq: DHC) announced that President and CEO Jennifer Francis will present at Nareit’s REITweek: 2022 Investor Conference on June 8, 2022, at 3:30 p.m. Eastern Time. A live audio webcast will be available on the company’s website, accessible 15 minutes before the presentation begins.
DHC is a REIT with approximately $6.8 billion in healthcare properties across 36 states and Washington, D.C., featuring over 27,500 senior living units and a life science portfolio of about nine million square feet.
Diversified Healthcare Trust (Nasdaq: DHC) announced that President Jennifer Francis and CFO Rick Siedel will meet investors at the 22nd Annual B. Riley Securities Institutional Investor Conference on May 25th, 2022, in Beverly Hills, CA. DHC is a real estate investment trust with approximately $6.8 billion in healthcare properties across 36 states and Washington, D.C. The company’s portfolio includes over 100 properties in life sciences and medical offices, totaling around nine million square feet, along with more than 27,500 senior living units.
AlerisLife (Nasdaq: ALR) announced that 53 of its communities were recognized by U.S. News and World Report in its inaugural "Best Senior Living" ratings, achieving the highest possible rating. This accolade highlights consumer satisfaction across various factors including community atmosphere, food quality, caregiving, and management. Notably, 46 of these rated communities are owned by Diversified Healthcare Trust (Nasdaq: DHC). The ratings are based on a survey of over 200,000 residents conducted between March 2021 and February 2022.
Diversified Healthcare Trust (Nasdaq: DHC) reported its Q1 2022 financial results, with net income of $240.4 million ($1.01 per share) and normalized FFO of $(21.9) million ($(0.09) per share). The company achieved a $327.5 million gain from a joint venture involving 10 Office Portfolio properties, adding $653 million in cash. Occupancy improved in the SHOP segment, reaching 73.0%. However, the Office Portfolio experienced declining occupancy rates, and DHC's liquidity ratio fell below the 1.5x requirement for incurring new debt. Cash and equivalents totaled approximately $1.5 billion.